Vita Life Sciences Limited provided earnings guidance for the half year ending June 30, 2022. For the period, the company expects sales to be $31.0 million to $32.0 million (H1 2021: $25.7 million).
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 AUD | -0.48% | -6.31% | +16.85% |
1st Jan change | Capi. | |
---|---|---|
+16.85% | 75.45M | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- VLS Stock
- News Vita Life Sciences Limited
- Vita Life Sciences Limited Provides Earnings Guidance for the Half Year Ending June 30, 2022